Vor Biopharma Inc. (VOR) Earnings History
Profitable8 years of earnings data (2018–2025) · Positive TTM net income
Loading earnings history...
Vor Biopharma Inc. (VOR) Earnings Overview
As of October 3, 2026, Vor Biopharma Inc. (VOR) reported trailing twelve-month net income of $628M, reflecting -107.4% year-over-year growth. The company earned $11.56 per diluted share over the past four quarters.
Looking at the long-term picture, VOR's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2018.
Vor Biopharma Inc. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including BEAM (-$85M net income, -57.2% margin), CRSP (-$451M net income, -16569.8% margin), EDIT (-$74M net income, -395.0% margin), VOR has comparable earnings metrics. Compare VOR vs BEAM →
VOR Earnings vs Peers
Earnings metrics vs comparable public companies
VOR Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$696M | -495.3% | -$372M | $-70.50 | - | - |
| 2024 | -$117M | +0.8% | -$121M | $-34.00 | - | - |
| 2023 | -$118M | -28.0% | -$126M | $-35.00 | - | - |
| 2022 | -$92M | -33.7% | -$93M | $-46.60 | - | - |
| 2021 | -$69M | -59.0% | -$69M | $-37.80 | - | - |
| 2020 | -$43M | -299.8% | -$43M | $-26.60 | - | - |
| 2019 | -$11M | -161.1% | -$10M | $-6.20 | - | - |
| 2018 | -$4M | - | -$3M | $-14.60 | - | - |
Download Data
Export VOR earnings history in CSV or JSON format
Free sign-in required to download data
VOR Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VOR — Frequently Asked Questions
Quick answers to the most common questions about buying VOR stock.
What is VOR earnings per share (EPS)?
VOR trailing twelve-month (TTM) diluted EPS is $11.56, reflecting -107.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Vor Biopharma Inc.'s net income?
Vor Biopharma Inc. (VOR) trailing twelve-month net income is $628M as of 2025. Earnings declined -107.4% year-over-year.
Is VOR profitable?
Yes, VOR is profitable with a TTM net income of $628M and a net profit margin of N/A.
What is VOR's earnings growth rate?
VOR compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are VOR's profit margins?
Vor Biopharma Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is VOR growing earnings?
VOR earnings are declining — EPS fell -107.4% year-over-year. TTM net income dropped to $628M. This contrasts with the 5-year CAGR of N/A.
What was VOR's best earnings year?
Vor Biopharma Inc.'s highest annual net income on record is $-4M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were VOR's earnings last quarter?
VOR's most recent reported quarter was Q2 2026. Net income was $-63M with diluted EPS of $-1.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.